Search research articles
Contact Us
Filters
Showing results (141-150 of 167) with videos related to
Page
of 17
Sort By:
Urology
|
December 1, 1996
The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancer
J Pannek, E N Subong, K A Jones, et al.
Anticancer Research
|
September 2, 1999
Multicenter evaluation of the Elecsys CA 125 II assay
W Hubl, D W Chan, H E Van Ingen, et al.
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
Prospective evaluation of percent free-PSA and complexed-PSA for early detection of prostate cancer
A W Partin, M K Brawer, E N P Subong, et al.
Cancer Research
|
June 15, 1992
Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease
H B Carter, C H Morrell, J D Pearson, et al.
Anticancer Research
|
June 9, 2001
Clinical utility of serum HER-2/neu testing on the Bayer Immuno 1 automated system in breast cancer
G B Cook, I E Neaman, J L Goldblatt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1988
A new biomarker in monitoring breast cancer: CA 549
R A Beveridge, D W Chan, D Bruzek, et al.
British Journal of Cancer
|
September 17, 2009
Overexpression of FOXG1 contributes to TGF-beta resistance through inhibition of p21WAF1/CIP1 expression in ovarian cancer
D W Chan, V W S Liu, R M Y To, et al.
The Journal of Biological Chemistry
|
May 10, 2000
Utilization of oriented peptide libraries to identify substrate motifs selected by ATM
T O'Neill, A J Dwyer, Y Ziv, et al.
The EMBO Journal
|
July 1, 1996
DNA-dependent protein kinase catalytic subunit: a target for an ICE-like protease in apoptosis
Q Song, S P Lees-Miller, S Kumar, et al.
The Journal of Urology
|
July 2, 1998
Influence of finasteride on free and total serum prostate specific antigen levels in men with benign prostatic hyperplasia
J Pannek, L S Marks, J D Pearson, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 167) with videos related to
Sort By:
Page
of 17
Urology
|
December 1, 1996
The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancer
J Pannek, E N Subong, K A Jones, et al.
Anticancer Research
|
September 2, 1999
Multicenter evaluation of the Elecsys CA 125 II assay
W Hubl, D W Chan, H E Van Ingen, et al.
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
Prospective evaluation of percent free-PSA and complexed-PSA for early detection of prostate cancer
A W Partin, M K Brawer, E N P Subong, et al.
Cancer Research
|
June 15, 1992
Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease
H B Carter, C H Morrell, J D Pearson, et al.
Anticancer Research
|
June 9, 2001
Clinical utility of serum HER-2/neu testing on the Bayer Immuno 1 automated system in breast cancer
G B Cook, I E Neaman, J L Goldblatt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1988
A new biomarker in monitoring breast cancer: CA 549
R A Beveridge, D W Chan, D Bruzek, et al.
British Journal of Cancer
|
September 17, 2009
Overexpression of FOXG1 contributes to TGF-beta resistance through inhibition of p21WAF1/CIP1 expression in ovarian cancer
D W Chan, V W S Liu, R M Y To, et al.
The Journal of Biological Chemistry
|
May 10, 2000
Utilization of oriented peptide libraries to identify substrate motifs selected by ATM
T O'Neill, A J Dwyer, Y Ziv, et al.
The EMBO Journal
|
July 1, 1996
DNA-dependent protein kinase catalytic subunit: a target for an ICE-like protease in apoptosis
Q Song, S P Lees-Miller, S Kumar, et al.
The Journal of Urology
|
July 2, 1998
Influence of finasteride on free and total serum prostate specific antigen levels in men with benign prostatic hyperplasia
J Pannek, L S Marks, J D Pearson, et al.
Page
of 17